Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Contraception and Contraceptive Drugs

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 19 articles:
HTML format



Single Articles


    August 2024
  1. RYDELIUS J, Hognert H, Kopp-Kallner H, Brandell K, et al
    First dose of misoprostol administration at home or in hospital for medical abortion between 12-22 gestational weeks in Sweden (PRIMA): a multicentre, open-label, randomised controlled trial.
    Lancet. 2024;404:864-873.
    PubMed     Abstract available


    August 2023
  2. CAHILL EP
    Adding a COX-2 inhibitor improves efficacy of emergency contraception.
    Lancet. 2023 Aug 16:S0140-6736(23)01612-4. doi: 10.1016/S0140-6736(23)01612.
    PubMed    


  3. LI RHW, Lo SST, Gemzell-Danielsson K, Fong CHY, et al
    Oral emergency contraception with levonorgestrel plus piroxicam: a randomised double-blind placebo-controlled trial.
    Lancet. 2023 Aug 16:S0140-6736(23)01240-0. doi: 10.1016/S0140-6736(23)01240.
    PubMed     Abstract available


    June 2023
  4. MARSTON C, Tabot M
    How can we put rights at the core of global family planning?
    Lancet. 2023;401:2096-2098.
    PubMed    


    May 2023
  5. MCCURRY J
    Japan approves abortion pill.
    Lancet. 2023;401:1558.
    PubMed    


    April 2023
  6. JAFFE S
    Drug developers caution against US mifepristone ban.
    Lancet. 2023;401:1325-1326.
    PubMed    


    September 2022
  7. DONNEZ J, Taylor HS, Stewart EA, Bradley L, et al
    Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials.
    Lancet. 2022;400:896-907.
    PubMed     Abstract available


    August 2022
  8. ENDLER M, Petro G, Gemzell Danielsson K, Grossman D, et al
    A telemedicine model for abortion in South Africa: a randomised, controlled, non-inferiority trial.
    Lancet. 2022;400:670-679.
    PubMed     Abstract available


    July 2022
  9. HAAKENSTAD A, Angelino O, Irvine CMS, Bhutta ZA, et al
    Measuring contraceptive method mix, prevalence, and demand satisfied by age and marital status in 204 countries and territories, 1970-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    Lancet. 2022;400:295-327.
    PubMed     Abstract available


  10. PRADHAN MR
    Contraceptive mix and informed choice.
    Lancet. 2022;400:255-257.
    PubMed    


  11. HIAM L, Mateescu I, Spiegel P
    Improving access to contraception and abortion in Romania in the context of the conflict in Ukraine.
    Lancet. 2022 Jul 8. pii: S0140-6736(22)01275.
    PubMed    


    June 2022
  12. BARTZ D
    Incidence of perforation with intrauterine devices.
    Lancet. 2022;399:2076-2077.
    PubMed    


    April 2022
  13. DELANY-MORETLWE S, Hughes JP, Bock P, Ouma SG, et al
    Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial.
    Lancet. 2022 Apr 1. pii: S0140-6736(22)00538.
    PubMed     Abstract available


    July 2021
  14. HOLT E
    Compensation for victims of sterilisation.
    Lancet. 2021;398:378.
    PubMed    


  15. WARASNA B, Rajabi N, Mustafa B, Najjar A, et al
    Knowledge and attitude of Palestinian women to contraceptives: a cross-sectional study.
    Lancet. 2021;398 Suppl 1:S45.
    PubMed     Abstract available


    November 2020
  16. CAMERON ST, Glasier A, McDaid L, Radley A, et al
    Use of effective contraception following provision of the progestogen-only pill for women presenting to community pharmacies for emergency contraception (Bridge-It): a pragmatic cluster-randomised crossover trial.
    Lancet. 2020;396:1585-1594.
    PubMed     Abstract available


  17. MARSTON C, Sowemimo A
    Bridge-It trial-a step towards better contraception services.
    Lancet. 2020;396:1536-1537.
    PubMed    


    August 2020
  18. CHU JJ, Devall AJ, Beeson LE, Hardy P, et al
    Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial.
    Lancet. 2020 Aug 24. pii: S0140-6736(20)31788.
    PubMed     Abstract available


  19. BARNHART K
    Medical management of miscarriage with mifepristone.
    Lancet. 2020 Aug 24. pii: S0140-6736(20)31789.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Contraception and Contraceptive Drugs is free of charge.